BGLAP and Parkinson disease: Finally, in vitro and in vivo data revealed that OCN could reduce dopaminergic neuronal injury induced by 6-OHDA via the AKT/GSK3β signaling pathway [48], which was claimed to be one of the pathophysiological mechanisms in the development of PD [58, 59] (Fig. 1).